secwatch.observer — SEC 8-K summary
======================================

Issuer:     IONIS PHARMACEUTICALS INC (IONS)
CIK:        0000874015
Form:       8-K
Filed at:   2023-08-04T23:59:59+00:00
Accession:  0001140361-23-038087
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

IONIS terminates lease for 217K sq ft Oceanside facility after landlord misses July 31 grading milestone
--------------------------------------------------------------------------------

- Notified Sudberry Development of termination under Section 2.3 of Lease due to failure to commence grading by July 31, 2023.
- Lease for ~217,000 rentable sq ft manufacturing/R&D/office/warehouse on 13.1 acres in Oceanside, CA; base rent at fair market value based on construction cost.
- Termination effective Aug 31, 2023 unless landlord achieves milestone by then; no further rights or obligations after.
- Company states termination will not impact ability to successfully commercialize its medicines.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/874015/000114036123038087/0001140361-23-038087-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/874015/000114036123038087/brhc20056999_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-038087

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer